About Merakris
Merakris Therapeutics is a clinical-stage biotechnology company singularly focused on the research, development and commercialization of regenerative healthcare products.
Founded in 2016, Merakris builds on its years of scientific research to develop cutting-edge precision, cell-free regenerative therapies across multiple indications.
In addition to a robust pipeline including an investigational new drug, MTX-001, a subcutaneous injectable for VLU healing, we offer commercially available, cell-free wound coverings for general wound care and ophthalmic applications.